NEW Event operating system uses AI-assisted workflows, and contextual automation across event operations Integrating ...
Create is expected to achieve double-digit year-over-year revenue growth in Q1, excluding nonstrategic revenue, with a similar cadence throughout 2026. Adjusted EBITDA margins are anticipated to ...
FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...
Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...
After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by ...
Vector Solutions released its TargetSolutions Volunteer Edition, a training platform helps volunteer fire departments meet ...
The first phase of the Pentagon's drone competition, Gauntlet, begins later this month. US drone operators will fly and test ...
More than 30 Texas companies, including some around San Antonio and Austin, are part of a Pentagon program that Homeland ...
Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results